A PCR-based microwell-plate hybrid capture assay for high-risk human papillomavirus

Arch Virol. 2014 Dec;159(12):3365-70. doi: 10.1007/s00705-014-2186-0. Epub 2014 Aug 5.

Abstract

Human papillomavirus (HPV) is associated with cervical cancer. In this study, we developed a high-throughput microwell-plate hybrid capture (MPHC) method for epidemiological studies of high-risk HPV (HRHPV). The results with 1238 cervical specimens from female outpatients showed a concordance rate of 94.3 % between the MPHC and Hybrid Capture II assay. The MPHC assay showed an average HRHPV rate of 29.3 % for high-risk populations in populous cities of China. The established MPHC assay could sensitively and specifically detect 13 types of HRHPV and is suitable for large-scale screening, especially in areas where real-time PCR or fluorescence equipment is unavailable.

Publication types

  • Evaluation Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • China
  • Cities
  • Humans
  • Mass Screening / methods
  • Molecular Diagnostic Techniques / methods*
  • Molecular Epidemiology / methods
  • Papillomaviridae / isolation & purification*
  • Papillomavirus Infections / diagnosis*
  • Polymerase Chain Reaction / methods*
  • Sensitivity and Specificity